Literature DB >> 30070327

Increased expression of long noncoding RNA LINC00961 suppresses glioma metastasis and correlates with favorable prognosis.

X-W Lu1, N Xu, Y-G Zheng, Q-X Li, J-S Shi.   

Abstract

OBJECTIVE: Long non-coding RNA LINC00961 (LINC00961) has been reported to play an important role in tumor development and metastasis of lung cancer. However, the expression and role of LINC00961 in glioma remains unclear. The present study aimed to investigate the expression of LINC00961 in patients with glioma and to investigate its effect on glioma cells. PATIENTS AND METHODS: Quantitative Real-Time PCR (qRT-PCR) was performed to detect the expression of LINC00961 in glioma tissues and cell lines. Then, the association between LINC00961 expression and clinical pathological parameters and prognosis of glioma patients were further evaluated. Gain of function studies were performed to determine the effects of LINC00961 on proliferation and metastasis of glioma cells. Western blotting assay was used to explore the regulation mechanism.
RESULTS: We found that LINC00961 was significantly downregulated in glioma tissues and cell lines compared with that of adjacent normal brain tissues and normal human astrocytes. Low expression of LINC00961 was significantly correlated with WHO grade and KPS score. Clinical analysis indicated that patients with low LINC00961 expression had a shorter overall survival than those with high expression. Univariate and multivariable Cox regression analyses further identified that down-regulated LINC00961 might act as an independent prognostic factor for glioma patients. Functionally, overexpression of LINC00961 significantly suppressed glioma cells proliferation, migration, and invasion. Mechanistically, we found that overexpression of LINC00961 inhibited glioma cell EMT.
CONCLUSIONS: LINC00961 might be considered as a novel molecule involved in glioma development, which provides an independent prognostic indicator and a potential therapeutic target for glioma patients.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30070327     DOI: 10.26355/eurrev_201808_15630

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  Evaluation of the potential role of long non-coding RNA LINC00961 in luminal breast cancer: a case-control and systems biology study.

Authors:  Sepideh Mehrpour Layeghi; Maedeh Arabpour; Rezvan Esmaeili; Mohammad Mehdi Naghizadeh; Javad Tavakkoly Bazzaz; Abbas Shakoori
Journal:  Cancer Cell Int       Date:  2020-10-02       Impact factor: 5.722

2.  LINC00961 functions as an anti-oncogene in non-small cell lung carcinoma by regulation of miR-3127.

Authors:  Yong-Gang Liu; Jia Li; Fang Nie; Gao-Wa Jin
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

3.  Two Novel Long Noncoding RNAs - RP11-296E3.2 and LEF1-AS1can - Separately Serve as Diagnostic and Prognostic Bio-Markers of Metastasis in Colorectal Cancer.

Authors:  Qian Shi; Ying He; Xilin Zhang; Jingjing Li; Ge Cui; Xiuping Zhang; Xiang Wang
Journal:  Med Sci Monit       Date:  2019-09-19

4.  Linc00961 inhibits the proliferation and invasion of skin melanoma by targeting the miR‑367/PTEN axis.

Authors:  Xin Mu; Kuan-Hou Mou; Rui Ge; Dan Han; Yan Zhou; Li-Juan Wang
Journal:  Int J Oncol       Date:  2019-07-25       Impact factor: 5.650

Review 5.  Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA.

Authors:  Pan Wu; Yongzhen Mo; Miao Peng; Ting Tang; Yu Zhong; Xiangying Deng; Fang Xiong; Can Guo; Xu Wu; Yong Li; Xiaoling Li; Guiyuan Li; Zhaoyang Zeng; Wei Xiong
Journal:  Mol Cancer       Date:  2020-02-04       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.